- Home
- GPRE vs LXEO Comparison
GPRE vs LXEO Comparison
Compare GPRE & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPRE | LXEO |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Major Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 812.2M | 731.3M |
| IPO Year | 2004 | 2023 |
Fundamental Metrics
Financial Performance| Metric | GPRE | LXEO |
|---|---|---|
| Price | $13.58 | $6.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | $10.61 | ★ $18.60 |
| AVG Volume (30 Days) | ★ 1.6M | 751.2K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,091,680,000.00 | $654,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.14 | $1.45 |
| 52 Week High | $15.64 | $10.99 |
Technical Indicators
Market Signals| Indicator | GPRE | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 58.60 | 29.84 |
| Support Level | $13.12 | $6.03 |
| Resistance Level | $15.64 | $6.51 |
| Average True Range (ATR) | 0.97 | 0.48 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 55.41 | 12.18 |
Price Performance
Historical ComparisonAbout GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.